ZA962847B - Treatment of traveller's diarrhea. - Google Patents

Treatment of traveller's diarrhea.

Info

Publication number
ZA962847B
ZA962847B ZA9602847A ZA962847A ZA962847B ZA 962847 B ZA962847 B ZA 962847B ZA 9602847 A ZA9602847 A ZA 9602847A ZA 962847 A ZA962847 A ZA 962847A ZA 962847 B ZA962847 B ZA 962847B
Authority
ZA
South Africa
Prior art keywords
traveller
diarrhea
treatment
Prior art date
Application number
ZA9602847A
Other languages
English (en)
Inventor
Louis D Heerze
Glen D Armstrong
Original Assignee
Synsorb Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synsorb Biotech Inc filed Critical Synsorb Biotech Inc
Publication of ZA962847B publication Critical patent/ZA962847B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9602847A 1995-06-05 1996-04-10 Treatment of traveller's diarrhea. ZA962847B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/461,294 US5627163A (en) 1995-06-05 1995-06-05 Treatment of traveller's diarrhea

Publications (1)

Publication Number Publication Date
ZA962847B true ZA962847B (en) 1997-02-24

Family

ID=23831988

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9602847A ZA962847B (en) 1995-06-05 1996-04-10 Treatment of traveller's diarrhea.

Country Status (10)

Country Link
US (1) US5627163A (fr)
EP (1) EP0831914A1 (fr)
JP (1) JPH11506458A (fr)
AU (1) AU713668B2 (fr)
CA (1) CA2210193A1 (fr)
IL (1) IL117655A (fr)
NZ (2) NZ302632A (fr)
TW (1) TW474814B (fr)
WO (1) WO1996039190A1 (fr)
ZA (1) ZA962847B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914114A (en) * 1995-06-02 1999-06-22 The United States Of America As Represented By The Secretary Of The Army Method of raising antibodies against E. coli of the family CS4-CFA/I
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US5891860A (en) * 1996-03-11 1999-04-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US6069137A (en) * 1996-03-11 2000-05-30 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5932554A (en) * 1996-11-14 1999-08-03 Synsorb Biotech, Inc. 1-galactose derivatives
US6174867B1 (en) * 1998-05-08 2001-01-16 Synsorb Biotech, Inc. 1-galactose derivatives having a carbon- or nitrogen-containing aglycon linkage
US6291435B1 (en) * 1999-03-04 2001-09-18 The Governs Of The University Of Alberta Treatment of diarrhea caused by enteropathogenic Escherichia coli
AUPQ275799A0 (en) * 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
EP1372708B1 (fr) * 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccin pour immunisation transcutanee contre la diarrhée de voyageurs
EP1531832B1 (fr) * 2002-06-28 2009-04-15 Glykos Finland Oy Compositions therapeutiques servant a la prophylaxie ou au traitement de diarrhees
WO2007117175A1 (fr) * 2006-04-10 2007-10-18 Avva Pharmaceuticals Ag Composition pharmaceutique d'entérosorbant et de prébiotiques, formes galéniques et procédé pour la prévention et le traitement de troubles gastrointestinaux

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
EP1018342A3 (fr) * 1991-10-18 2001-04-11 SYNSORB Biotech Inc. Diagnostic et traitement de la dysenterie bactérienne
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea

Also Published As

Publication number Publication date
IL117655A (en) 2000-08-31
CA2210193A1 (fr) 1996-12-12
AU713668B2 (en) 1999-12-09
TW474814B (en) 2002-02-01
JPH11506458A (ja) 1999-06-08
EP0831914A1 (fr) 1998-04-01
WO1996039190A1 (fr) 1996-12-12
AU4873296A (en) 1996-12-24
NZ302632A (en) 1999-11-29
NZ337148A (en) 2001-02-23
IL117655A0 (en) 1996-07-23
US5627163A (en) 1997-05-06

Similar Documents

Publication Publication Date Title
AU3590897A (en) Traveler's quarters
AU6513096A (en) Treatment of fabrics
ZA962846B (en) Treatment of traveller's diarrhea
GR3033254T3 (en) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
EP0754407A3 (fr) Compositions liquides de 1,2-benzisothiazolin-3-one
GB2276178B (en) Treatment of textiles
ZA962847B (en) Treatment of traveller's diarrhea.
GB9503794D0 (en) Treatment of fabrics
GB9518692D0 (en) 'Spraymate'
EP0852503A4 (fr) Composition pour le traitement de la diarrhee, son utilisation et sa preparation
IL113057A0 (en) Compositions for the treatment of dandruff
ZA931063B (en) Treatment of glaucoma.
GB9522028D0 (en) Treatment of fabrics
GB9505681D0 (en) "Treatment"
GB9424471D0 (en) Treatment of emesis
ZA956912B (en) Traveller's cheque book
PL102928U1 (en) Traveller's tooth-brush
KR950002801U (ko) 리 메니큐어(LEE'S Manicure)
ZA987698B (en) "Treatment of water".
PL103994U1 (en) Preambulator's body
GR1001852B (en) Dental technical's photopolymerism chamber.
GB9508611D0 (en) Als "truklok"
GB9520215D0 (en) 70 something's local guide
GB9504799D0 (en) Correct use of energy (part 1)
EG20666A (en) Anhydroussilica precipitate " sio"2